PRL and pituitary tumor: Other somatic changes suggested to be associated with pituitary tumors include: PIK3CA amplification (127, 128), IDH1 mutations (129, 130), TP53 in pituitary carcinomas (131) and ACTH-PTs (132), and HMGA2 amplification in PRL-PTs (133–135).